A detailed history of Camden Capital, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Camden Capital, LLC holds 3,782 shares of VRTX stock, worth $1.71 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,782
Previous 4,519 16.31%
Holding current value
$1.71 Million
Previous $2.12 Million 17.0%
% of portfolio
0.2%
Previous 0.17%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$460.0 - $505.78 $339,020 - $372,759
-737 Reduced 16.31%
3,782 $1.76 Million
Q2 2024

Aug 06, 2024

BUY
$392.81 - $485.53 $169,301 - $209,263
431 Added 10.54%
4,519 $2.12 Million
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $614,796 - $672,688
1,508 Added 58.45%
4,088 $1.71 Million
Q4 2023

Feb 05, 2024

BUY
$343.0 - $410.68 $148,519 - $177,824
433 Added 20.17%
2,580 $1.05 Million
Q3 2023

Nov 03, 2023

BUY
$338.18 - $362.46 $114,643 - $122,873
339 Added 18.75%
2,147 $746,000
Q2 2023

Aug 09, 2023

BUY
$314.42 - $351.91 $258,138 - $288,918
821 Added 83.18%
1,808 $636,000
Q1 2023

May 11, 2023

BUY
$283.23 - $323.1 $39,935 - $45,557
141 Added 16.67%
987 $310,000
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $770,694 - $867,031
-2,697 Reduced 76.12%
846 $244,000
Q3 2022

Nov 08, 2022

BUY
$273.83 - $305.53 $754,127 - $841,429
2,754 Added 349.05%
3,543 $1.03 Million
Q2 2022

Aug 03, 2022

SELL
$234.96 - $292.55 $102,442 - $127,551
-436 Reduced 35.59%
789 $222,000
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $18,763 - $23,685
106 Added 9.47%
1,225 $269,000
Q3 2021

Nov 03, 2021

SELL
$181.39 - $202.99 $6,530 - $7,307
-36 Reduced 3.12%
1,119 $204,000
Q2 2021

Aug 16, 2021

SELL
$187.49 - $221.1 $4,312 - $5,085
-23 Reduced 1.95%
1,155 $233,000
Q1 2021

May 10, 2021

BUY
$207.02 - $241.31 $38,919 - $45,366
188 Added 18.99%
1,178 $253,000
Q4 2020

Feb 04, 2021

BUY
$207.01 - $276.09 $204,939 - $273,329
990 New
990 $234,000
Q2 2020

Aug 11, 2020

SELL
$225.48 - $295.8 $326,044 - $427,726
-1,446 Closed
0 $0
Q1 2020

Apr 13, 2020

SELL
$199.77 - $247.81 $6,192 - $7,682
-31 Reduced 2.1%
1,446 $338,000
Q4 2019

Feb 10, 2020

BUY
$166.71 - $223.91 $246,230 - $330,715
1,477 New
1,477 $323,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.